Literature DB >> 20165898

In front of and behind the replication fork: bacterial type IIA topoisomerases.

Claudia Sissi1, Manlio Palumbo.   

Abstract

Topoisomerases are vital enzymes specialized in controlling DNA topology, in particular supercoiling and decatenation, to properly handle nucleic acid packing and cell dynamics. The type IIA enzymes act by cleaving both strands of a double helix and having another strand from the same or another molecule cross the DNA gate before a re-sealing event completes the catalytic cycle. Here, we will consider the two types of IIA prokaryotic topoisomerases, DNA Gyrase and Topoisomerase IV, as crucial regulators of bacterial cell cycle progression. Their synergistic action allows control of chromosome packing and grants occurrence of functional transcription and replication processes. In addition to displaying a fascinating molecular mechanism of action, which transduces chemical energy into mechanical energy by means of large conformational changes, these enzymes represent attractive pharmacological targets for antibacterial chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20165898     DOI: 10.1007/s00018-010-0299-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  189 in total

1.  Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.

Authors:  D Fass; C E Bogden; J M Berger
Journal:  Nat Struct Biol       Date:  1999-04

2.  Under DNA stress, gyrase makes the sign of the cross.

Authors:  N Patrick Higgins
Journal:  Nat Struct Mol Biol       Date:  2007-04       Impact factor: 15.369

3.  Simplification of DNA topology below equilibrium values by type II topoisomerases.

Authors:  V V Rybenkov; C Ullsperger; A V Vologodskii; N R Cozzarelli
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

4.  Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.

Authors:  X S Pan; L M Fisher
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

5.  The DNA-gate of Bacillus subtilis gyrase is predominantly in the closed conformation during the DNA supercoiling reaction.

Authors:  Airat Gubaev; Manuel Hilbert; Dagmar Klostermeier
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-29       Impact factor: 11.205

6.  Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.

Authors:  Sergio Madurga; Javier Sánchez-Céspedes; Ignasi Belda; Jordi Vila; Ernest Giralt
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164

7.  In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.

Authors:  Gregory T Robertson; Eric J Bonventre; Timothy B Doyle; Qun Du; Leonard Duncan; Timothy W Morris; Eric D Roche; Dalai Yan; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 8.  Recent advances in bacterial topoisomerase inhibitors.

Authors:  Barton J Bradbury; Michael J Pucci
Journal:  Curr Opin Pharmacol       Date:  2008-06-12       Impact factor: 5.547

9.  Small-angle X-ray scattering reveals the solution structure of the full-length DNA gyrase a subunit.

Authors:  Lionel Costenaro; J Günter Grossmann; Christine Ebel; Anthony Maxwell
Journal:  Structure       Date:  2005-02       Impact factor: 5.006

10.  Multiple modes of Escherichia coli DNA gyrase activity revealed by force and torque.

Authors:  Marcelo Nöllmann; Michael D Stone; Zev Bryant; Jeff Gore; Nancy J Crisona; Seok-Cheol Hong; Sylvain Mitelheiser; Anthony Maxwell; Carlos Bustamante; Nicholas R Cozzarelli
Journal:  Nat Struct Mol Biol       Date:  2007-03-04       Impact factor: 15.369

View more
  26 in total

1.  Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases.

Authors:  Laura Casu; Filippo Cottiglia; Marco Leonti; Alessandro De Logu; Emanuela Agus; Yuk-Ching Tse-Dinh; Valentina Lombardo; Claudia Sissi
Journal:  Bioorg Med Chem Lett       Date:  2011-10-01       Impact factor: 2.823

2.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

Review 3.  A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.

Authors:  Gregory S Bisacchi; Michael R Hale
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

4.  Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.

Authors:  Elizabeth G Gibson; Ben Bax; Pan F Chan; Neil Osheroff
Journal:  ACS Infect Dis       Date:  2019-02-28       Impact factor: 5.084

5.  Functional interactions between gyrase subunits are optimized in a species-specific manner.

Authors:  Daniela Weidlich; Dagmar Klostermeier
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

6.  Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons.

Authors:  Elizabeth G Gibson; Tim R Blower; Monica Cacho; Ben Bax; James M Berger; Neil Osheroff
Journal:  ACS Infect Dis       Date:  2018-05-17       Impact factor: 5.084

Review 7.  What makes a type IIA topoisomerase a gyrase or a Topo IV?

Authors:  Jana Hirsch; Dagmar Klostermeier
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

Review 8.  Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.

Authors:  Yves Pommier; Yilun Sun; Shar-Yin N Huang; John L Nitiss
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-21       Impact factor: 113.915

Review 9.  Quinolones: from antibiotics to autoinducers.

Authors:  Stephan Heeb; Matthew P Fletcher; Siri Ram Chhabra; Stephen P Diggle; Paul Williams; Miguel Cámara
Journal:  FEMS Microbiol Rev       Date:  2011-03       Impact factor: 16.408

10.  Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV.

Authors:  Steven L Pitts; Grace F Liou; Lesley A Mitchenall; Alex B Burgin; Anthony Maxwell; Keir C Neuman; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2011-02-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.